SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-19-287359
Filing Date
2019-11-07
Accepted
2019-11-07 16:34:54
Documents
33
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q d787025d10q.htm 10-Q 268288
2 EX-10.1 d787025dex101.htm EX-10.1 98848
3 EX-31.1 d787025dex311.htm EX-31.1 6682
4 EX-31.2 d787025dex312.htm EX-31.2 6685
5 EX-32.1 d787025dex321.htm EX-32.1 3350
6 EX-32.2 d787025dex322.htm EX-32.2 3291
  Complete submission text file 0001193125-19-287359.txt   1600333

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT hppi-20190930.xml EX-101.INS 207369
8 XBRL TAXONOMY EXTENSION SCHEMA hppi-20190930.xsd EX-101.SCH 18298
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE hppi-20190930_cal.xml EX-101.CAL 16102
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE hppi-20190930_def.xml EX-101.DEF 96783
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE hppi-20190930_lab.xml EX-101.LAB 162074
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE hppi-20190930_pre.xml EX-101.PRE 126822
Mailing Address 324 SOUTH HYDE PARK AVENUE SUITE 350 TAMPA FL 33606
Business Address 324 SOUTH HYDE PARK AVENUE SUITE 350 TAMPA FL 33606 (813) 864-2559
Inhibitor Therapeutics, Inc. (Filer) CIK: 0001042418 (see all company filings)

IRS No.: 541641133 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-13467 | Film No.: 191200885
SIC: 8731 Services-Commercial Physical & Biological Research